Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × Commerce × 30 days × Clear all

Sponsor

Interventions

fludarabine phosphate 5 Specimen Handling 5 Cyclophosphamide 5 pembrolizumab 4 fludarabine 4 Brentuximab Vedotin 4 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Doxorubicin 3 Dacarbazine 3 pegylated granulocyte colony-stimulating factor 2 pegfilgrastim 2 Whole-Body Irradiation 2 Vinblastine 2 Radiotherapy 2 Mycophenolic Acid 2 Melphalan 2 Gemcitabine 2 thymoglobulin 1 tazemetostat 1 sargramostim 1 polatuzumab vedotin 1 liposomal doxorubicin 1 letermovir 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 decitabine and cedazuridine drug combination 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡